Nyxoah’s $95 Million Follow-On Offering

Cleary Gottlieb represented the underwriters in a $95 million SEC-registered public offering by Nyxoah SA (Nyxoah) of 55,232,558 of its ordinary shares.

Nyxoah has granted the underwriters a 30-day option to purchase up to an additional 8,284,883 ordinary shares.

BofA Securities is acting as the lead bookrunner for the offering. Degroof Petercam is acting as an additional bookrunner, and B. Riley Securities is acting as a co-manager for the offering.

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apenea (OSA), the world’s most common sleep disordered breathing condition. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy for OSA.

For more information, please see the press release.

The Cleary corporate team included partners Ilir Mujalovic, Harald Halbhuber, Synne Chapman, and Alexis Raguet and associates Ilya Nekrasov, Taewan Roh, Alexandra Hansen, and Chad Kennon. Partner Matthew Brigham and associate Nathaniel Pribil advised on tax matters. Partners Marcela Robledo and Greg Sobolski and associates Natalie Curry and Ariana Croll advised on intellectual property and data privacy matters. Partner Samuel Chang and associate Kerry Mullins advised on regulatory matters. Senior attorneys James Corsiglia and Andres Saenz advised on financial regulatory matters.